Last December, when the United States Preventive Services Task Force recommended low-dose CT (LDCT) lung cancer screening for high-risk smokers, it was all but a foregone conclusion that the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) would follow suit and recommend it to be covered by Medicare. Of course, that narrative took a different turn this past April when MEDCAC voted not to recommend LDCT screening, much to the dismay of lung cancer screening advocates. But now, two recent studies seem have supplied evidence that supports lung cancer screening for Medicare patients.
Taking simple steps to reduce energy use can not only reduce the amount of energy a radiology department or practice consumes, but can result in significant cost savings, according to a study in the journal Academic Radiology.
A secondary analysis of the National Lung Screening Trial has found that low-dose lung cancer screening is actually more effective for older high-risk patients than it is for younger ones, according to a study in the Annals of Internal Medicine.
Iodine-based contrast material injected intravenously to enhance CT images is safe for most patients, according to a study published online in the journal Radiology.
A survey of hospital executives has determined that the U.S. healthcare system spends at least $7.47 billion, and as much as $11.95 billion on unnecessary imaging every year.
Personal touch from clinicians in the form of reminder postcards and physician-signed letters can improve breast cancer screening rates, according to a Canadian study presented at the American Society of Clinical Oncology Breast Cancer Symposium in San Francisco this past weekend.
Low-dose CT lung cancer screening is cost-effective and saves lives, according to a new study in American Health and Drug Benefits.
The use of CT angiography to diagnose emergency department patients presenting with chest pain can reduce unnecessary hospitalizations, according to a study published in the September issue of Radiology.
Doctors may be performing too many surveillance colonoscopies on patients who have had pre-cancerous polyps removed during an earlier colon cancer screening procedures, according to a study published recently in the New England Journal of Medicine.
The introduction of mammography and colonoscopy back in the 1960s helped introduce an "age of wonder" for cancer screening that correlated with a significant drop in mortality rates, according to Cary Gross, M.D., of Yale Medical School. Conversely, according to Gross, the 21st Century has launched a new age of wonder in the sense that people are now wondering how beneficial cancer screening actually is.